COVID-19

Industry Watch

In the second week of July, we bring you news of developments in HIV research, as well as updates on immunotherapies, Alzheimer’s disease,…

PRA Teams with Microsoft to Enhance COVID-19 Monitoring

Over the past several months, participants in PRA Health Sciences’ Health Harmony COVID-19 Monitoring Program have had vital information about…

How do we safely send kids to school during a pandemic?

The COVID-19 pandemic has led to the nationwide closure of schools and universities in more than 190 countries, impacting 1.57 billion students.

5 Ways to Maintain Regulatory Consistency During a Global Pandemic

Governments and businesses around the world continue to respond to the rapidly evolving COVID-19 disease, caused by an outbreak of a novel…

Looking Forward: COVID-19 Treatments, Vaccines, and Distribution

COVID-19 will have both short-term and long-term impacts on society—many of which we’re already seeing today. With the number of cases multiplying,…

Responding to the COVID-19 Pandemic in More Ways Than One

PRA’s global response to the COVID-19 pandemic has been thoughtful and deliberate, keeping in mind not only our industry, but all the people our…

COVID-19 Prevents Children from Receiving Important Vaccinations

Measles is a highly contagious disease that often affects children, and may be fatal. Harris Dalrymple, PRA’s Executive Director of Scientific…

PRA Talks COVID-19 Impact on Rare Disease Clinical Trials with Patient Advocates

PRA’s Center for Rare Diseases understands that clinical trials are both a source of hope and care for people affected by a rare disease. The impact…

COVID-19 Impact on Rare Disease Clinical Trials

Rare disease patient organizations are coping with a broad range of other organizational challenges, including reduced funding, canceled fundraising…

Clinical Research and the COVID-19 Crisis Webinar